Fidaxomicin
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Optimal Treatment for Recurrent Clostridium Difficile (NCT02667418) | VA Office of Research and Development | 2016-02-19 |
Track Fidaxomicin automatically
Every clearance here is in the API, with alerts when new ones post.